BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.https://investorshangout.com/BiondVax-Pharmaceuticals-Ltd-BVXV-92107/en-usThu, 10 Sep 2026 05:21:20 GMTCopyright InvestorsHangout.comNetworkNewsWire: BC Study Uncovers Cause of Four Major Pediatric Allergies New research by scientists from https://investorshangout.com/post/view?id=6616396https://investorshangout.com/post/view?id=6616396Thu, 07 Sep 2023 21:18:46 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Rebrands as Scinai Immunotherapehttps://investorshangout.com/post/view?id=6615928https://investorshangout.com/post/view?id=6615928Wed, 06 Sep 2023 20:20:41 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwhttps://investorshangout.com/post/view?id=6614610https://investorshangout.com/post/view?id=6614610Fri, 01 Sep 2023 20:11:26 GMTNetworkNewsWire: Malaria Case Prompts Army to Ask Infectious Disease Experts to Analyze Mosquitoes A group https://investorshangout.com/post/view?id=6614213https://investorshangout.com/post/view?id=6614213Thu, 31 Aug 2023 20:52:55 GMTNetworkNewsWire: England Sees Soaring Numbers of Hospitalizations for Severe Allergies A leading national phttps://investorshangout.com/post/view?id=6613058https://investorshangout.com/post/view?id=6613058Mon, 28 Aug 2023 20:42:14 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Is Fast on the Trail to Target Ihttps://investorshangout.com/post/view?id=6612427https://investorshangout.com/post/view?id=6612427Fri, 25 Aug 2023 20:24:35 GMTNetworkNewsWire: How Allergy Sufferers Can Benefit from Immunotherapy The Centers for Disease Control and Phttps://investorshangout.com/post/view?id=6611138https://investorshangout.com/post/view?id=6611138Tue, 22 Aug 2023 21:31:37 GMTNetworkNewsWire: Analyzing Link Between Hormonal Contraceptives, Autoimmunity Autoimmune diseases occur whehttps://investorshangout.com/post/view?id=6609859https://investorshangout.com/post/view?id=6609859Fri, 18 Aug 2023 21:36:18 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Advances NanoAb Therapy as IL-17 Drug Candidate for https://investorshangout.com/post/view?id=6609858https://investorshangout.com/post/view?id=6609858Fri, 18 Aug 2023 21:30:21 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q2 Financial Report, Cohttps://investorshangout.com/post/view?id=6609025https://investorshangout.com/post/view?id=6609025Wed, 16 Aug 2023 21:17:50 GMTNetworkNewsWire: Stem Cell Transplants Followed by Immunotherapy Show Efficacy Against Pediatric Nerve Tumors https://investorshangout.com/post/view?id=6608590https://investorshangout.com/post/view?id=6608590Tue, 15 Aug 2023 20:55:33 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Alpaca-Derived Nanobodies for Potential Treatment https://investorshangout.com/post/view?id=6608153https://investorshangout.com/post/view?id=6608153Mon, 14 Aug 2023 21:04:40 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q2 Financial Report, Cohttps://investorshangout.com/post/view?id=6607225https://investorshangout.com/post/view?id=6607225Fri, 11 Aug 2023 20:20:10 GMTNetworkNewsWire: How Immunotherapy Outcomes Can Be Affected by Diet, Gut Microbiota Immunotherapy presents https://investorshangout.com/post/view?id=6606334https://investorshangout.com/post/view?id=6606334Wed, 09 Aug 2023 21:24:13 GMTNetworkNewsWire: Study Finds Link Between Food Allergies in Infants, Childhood Asthma Onset Researchers frohttps://investorshangout.com/post/view?id=6604267https://investorshangout.com/post/view?id=6604267Thu, 03 Aug 2023 20:35:47 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Granted Extension to Regain NASDhttps://investorshangout.com/post/view?id=6603746https://investorshangout.com/post/view?id=6603746Wed, 02 Aug 2023 20:38:45 GMTNetworkNewsWire: Review Shows AI Could Be Pivotal in Infectious Disease Prevention The worst of the coronavhttps://investorshangout.com/post/view?id=6602006https://investorshangout.com/post/view?id=6602006Fri, 28 Jul 2023 20:44:13 GMTNetworkNewsWire: NetworkNewsBreaks — BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Unique NanoAb Pipelinhttps://investorshangout.com/post/view?id=6601989https://investorshangout.com/post/view?id=6601989Fri, 28 Jul 2023 20:24:58 GMTNetworkNewsWire: M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharhttps://investorshangout.com/post/view?id=6601087https://investorshangout.com/post/view?id=6601087Wed, 26 Jul 2023 21:03:14 GMTNetworkNewsWire: Psoriasis Could Be Behind Frequent Fatigue Psoriasis is a topical condition that causes drhttps://investorshangout.com/post/view?id=6599898https://investorshangout.com/post/view?id=6599898Mon, 24 Jul 2023 21:30:53 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) CDMO Services Designed to Meethttps://investorshangout.com/post/view?id=6599815https://investorshangout.com/post/view?id=6599815Mon, 24 Jul 2023 20:19:21 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) CEO Amir Reichman Featured on IBN’s The Bell2Bell Pohttps://investorshangout.com/post/view?id=6598092https://investorshangout.com/post/view?id=6598092Wed, 19 Jul 2023 21:22:59 GMTNetworkNewsWire: Shining the Spotlight on Asthma During Pregnancy Asthma is a respiratory condition that afhttps://investorshangout.com/post/view?id=6597626https://investorshangout.com/post/view?id=6597626Tue, 18 Jul 2023 20:56:14 GMTNetworkNewsWire: Study Links Gut Flora to Onset of Pediatric Rheumatism The human body comprises many complhttps://investorshangout.com/post/view?id=6595562https://investorshangout.com/post/view?id=6595562Wed, 12 Jul 2023 21:27:18 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Sees Hot Market Potential for NanoAb Pipeline https://investorshangout.com/post/view?id=6595541https://investorshangout.com/post/view?id=6595541Wed, 12 Jul 2023 20:17:02 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Bell2Bell Podcasthttps://investorshangout.com/post/view?id=6595050https://investorshangout.com/post/view?id=6595050Tue, 11 Jul 2023 20:06:07 GMTNetworkNewsWire: Study Concludes That Long COVID Should Be Treated Holistically Although the world is throuhttps://investorshangout.com/post/view?id=6593506https://investorshangout.com/post/view?id=6593506Thu, 06 Jul 2023 21:10:41 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Offering to Include Boutique End-to-End CDMOhttps://investorshangout.com/post/view?id=6592459https://investorshangout.com/post/view?id=6592459Mon, 03 Jul 2023 19:13:29 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Well Positioned to Move next Nanhttps://investorshangout.com/post/view?id=6592452https://investorshangout.com/post/view?id=6592452Mon, 03 Jul 2023 19:04:52 GMTNetworkNewsWire: Exploring the Link Between Hypertension, Asthma On average, asthma affects close to 26 milhttps://investorshangout.com/post/view?id=6591403https://investorshangout.com/post/view?id=6591403Thu, 29 Jun 2023 21:00:32 GMTNetworkNewsWire: Why Women with MS See Decreased Symptoms When Pregnant Most people with multiple sclerosishttps://investorshangout.com/post/view?id=6589156https://investorshangout.com/post/view?id=6589156Fri, 23 Jun 2023 20:35:30 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Gains Exclusive Development and Commercialization Lihttps://investorshangout.com/post/view?id=6588707https://investorshangout.com/post/view?id=6588707Thu, 22 Jun 2023 20:22:09 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Focus with Development of New NanoAb Therapehttps://investorshangout.com/post/view?id=6587663https://investorshangout.com/post/view?id=6587663Tue, 20 Jun 2023 20:17:11 GMTNetworkNewsWire: Research Shows Autoimmune Ailments Rising The European Alliance of Associations for Rheumahttps://investorshangout.com/post/view?id=6586791https://investorshangout.com/post/view?id=6586791Fri, 16 Jun 2023 21:21:14 GMTNetworkNewsWire: Transplant Medicine Plagued by Organ Shortages, Pandemic-Induced Challenges In November 20https://investorshangout.com/post/view?id=6584873https://investorshangout.com/post/view?id=6584873Mon, 12 Jun 2023 21:28:21 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Big Pharma Competencihttps://investorshangout.com/post/view?id=6584862https://investorshangout.com/post/view?id=6584862Mon, 12 Jun 2023 21:11:51 GMTNetworkNewsWire: New Computational Platform to Broaden Options of Potential Immunotherapy Targets in Cancer Treatmhttps://investorshangout.com/post/view?id=6582952https://investorshangout.com/post/view?id=6582952Tue, 06 Jun 2023 20:59:22 GMTNetworkNewsWire: New Computational Platform to Broaden Options of Potential Immunotherapy Targets in Cancer Treatmhttps://investorshangout.com/post/view?id=6582951https://investorshangout.com/post/view?id=6582951Tue, 06 Jun 2023 20:59:08 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Displays CDMO Expertise at Prestigious Biomed Israelhttps://investorshangout.com/post/view?id=6581867https://investorshangout.com/post/view?id=6581867Fri, 02 Jun 2023 21:00:54 GMTNetworkNewsWire: Researchers ID Promising Strategy Against Immunotherapy Side Effects Researchers from the https://investorshangout.com/post/view?id=6581023https://investorshangout.com/post/view?id=6581023Wed, 31 May 2023 20:36:56 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Receives Buy Rating and $70 Target Price; Releases Qhttps://investorshangout.com/post/view?id=6580452https://investorshangout.com/post/view?id=6580452Tue, 30 May 2023 20:01:00 GMTNetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Provides Business Update, Reports FY2022 Financial Rhttps://investorshangout.com/post/view?id=6579183https://investorshangout.com/post/view?id=6579183Thu, 25 May 2023 20:30:33 GMTNetworkNewsWire: New Evidence Proves Link Between Glandular Fever Virus and MS Multiple sclerosis is a debihttps://investorshangout.com/post/view?id=6578655https://investorshangout.com/post/view?id=6578655Wed, 24 May 2023 21:16:41 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Looking to Complement Core Focushttps://investorshangout.com/post/view?id=6577742https://investorshangout.com/post/view?id=6577742Mon, 22 May 2023 20:02:53 GMTNetworkNewsWire: African Researchers Collaborate to Gather Data on Infectious Illnesses Infectious diseaseshttps://investorshangout.com/post/view?id=6576657https://investorshangout.com/post/view?id=6576657Thu, 18 May 2023 21:04:08 GMTNetworkNewsWire: NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q1 2023 Financial Resulhttps://investorshangout.com/post/view?id=6575601https://investorshangout.com/post/view?id=6575601Tue, 16 May 2023 21:05:59 GMTNetworkNewsWire: Study Finds 10% of People in UK Have Autoimmune Disorders New research has found that one https://investorshangout.com/post/view?id=6573324https://investorshangout.com/post/view?id=6573324Wed, 10 May 2023 21:26:04 GMTNetworkNewsWire: Researchers ID Antivirals That Can Fight New Infectious Illnesses New research has found bhttps://investorshangout.com/post/view?id=6571443https://investorshangout.com/post/view?id=6571443Fri, 05 May 2023 20:52:19 GMTNetworkNewsWire: Study Shows that Skin Conditions May Indicate Presence of Rheumatic Disease New research hhttps://investorshangout.com/post/view?id=6569083https://investorshangout.com/post/view?id=6569083Mon, 01 May 2023 20:34:22 GMTNetworkNewsWire: Three Data-Management Lessons that Healthcare Can Learn from Other Fields Data management https://investorshangout.com/post/view?id=6566497https://investorshangout.com/post/view?id=6566497Tue, 25 Apr 2023 20:42:02 GMT